A recent meta-analysis evaluated the accuracy of EN2 protein in urine as a biological marker in prostate cancer, indicating that the urinary EN2 presented a high specificity (89%) and low sensitivity (66%) [24]. Here, EN2 is linked to prostate carcinoma.